Sinohealth Holdings (HKSE:02361) Change In Receivables : HK$-15.8 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sinohealth Holdings Change In Receivables?

Sinohealth Holdings's change in receivables for the quarter that ended in Dec. 2024 was HK$-2.0 Mil. It means Sinohealth Holdings's Accounts Receivable increased by HK$2.0 Mil from Jun. 2024 to Dec. 2024 .

Sinohealth Holdings's change in receivables for the fiscal year that ended in Dec. 2024 was HK$-15.7 Mil. It means Sinohealth Holdings's Accounts Receivable increased by HK$15.7 Mil from Dec. 2023 to Dec. 2024 .

Sinohealth Holdings's Accounts Receivable for the quarter that ended in Dec. 2024 was HK$96.7 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sinohealth Holdings's Days Sales Outstanding for the six months ended in Dec. 2024 was 67.72.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sinohealth Holdings's liquidation value for the six months ended in Dec. 2024 was HK$561.7 Mil.

Sinohealth Holdings Change In Receivables Historical Data

The historical data trend for Sinohealth Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinohealth Holdings Change In Receivables Chart

Sinohealth Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-11.70

-68.25

-14.22

-17.18

-15.69

Sinohealth Holdings Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial					-26.47	14.07	-31.25	-13.82	-1.98

Sinohealth Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-15.8 Mil.

Sinohealth Holdings (HKSE:02361) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sinohealth Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	96.745	/	260.722	*	91
=	67.72

2. In Ben Graham's calculation of liquidation value, Sinohealth Holdings's accounts receivable are only considered to be worth 75% of book value:

Sinohealth Holdings's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	597.528	-	108.998	+	0.75 * 96.745	+	0.5 * 1.158
=	561.7

Sinohealth Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sinohealth Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinohealth Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinohealth Holdings Ltd (HKSE:02361) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Wangjiang Second Street, Room 1111, Huangge Town, Nansha District, Guangdong Province, Guangzhou City, CHN

Website

https://ir.sinohealth.cn

Sinohealth is a leading provider of Big Data and artificial intelligence-based marketing and distribution information tools, including SaaS-based customer relationship management solutions to mainland China medical product manufacturers. It sources retail data through pharmacy partnerships and provides data analysis to the pharmaceutical and corporate clients it serves. Since its establishment in 2007, its focus has been on building a strong Big Data engine and networking capabilities to assist clients in their product investments and sales and marketing strategies. It is now launching various cloud-based systems and platform solutions for its clients and expanding its SaaS products, which are expected to be the key growth driver in future.

Executives

Futu Trustee Limited	2301 Trustee
Shanghai Tianyi Assets Management Co., Ltd	2201 Interest of corporation controlled by you
Yu Rong	2201 Interest of corporation controlled by you
Tianyi (bvi) Limited	2101 Beneficial owner
Shang Hai Xuan Yu Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Rikan Industry Investment Limited Partnership
Wang Lifang	2201 Interest of corporation controlled by you
Wu Yushu	2201 Interest of corporation controlled by you
Wlf Investment Holdings Limited	2101 Beneficial owner
Li Hanxiong	2201 Interest of corporation controlled by you
Montesy Capital Holding Ltd	2101 Beneficial owner
Wu Meirong	2202 Interest of your spouse
Ying Lian You Xian Gong Si	2101 Beneficial owner

Sinohealth Holdings Headlines

No Headlines